⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9400046 | 0.77 | — | — | |
| SCHEMBL1434436 | 0.62 | — | — | |
| SCHEMBL9146844 | 0.60 | — | — | |
| SCHEMBL22276023 | 0.59 | — | — | |
| SCHEMBL12256561 | 0.56 | — | — | |
| SCHEMBL17176458 | 0.56 | — | — | |
| SCHEMBL1434434 | 0.56 | — | — | |
| SCHEMBL22785766 | 0.56 | — | — | |
| SCHEMBL2754315 | 0.56 | — | — | |
| SCHEMBL7778993 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6815437-B1 | VIRGINIAMYCINS AS BACTERICIDES; PRISTINAMYCIN CHEMICAL INTERMEDIATES | AVENTIS PHARMA S.A. (FR) | 2004-11-09 | — | — | US | claimed |
| US-11648254-B2 | Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signaling | KUMQUAT BIOSCIENCES INC. (US) | 2023-05-16 | — | — | US | disclosed |
| US-20210009587-A1 | ERBB RECEPTOR INHIBITORS | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2021-01-14 | — | — | US | disclosed |